(Q34084259)

30 July 2017

1 reference

title

Capecitabine: preclinical pharmacology studies (English)

1 reference

30 July 2017

1 reference

1 reference

H Ishitsuka

1

1 reference

30 July 2017

publication date

1 November 2000

1 reference

Investigational New Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

343-354

1 reference

Interactions of interferon-alpha 2a with 5'-deoxy-5-fluorouridine in colorectal cancer cells in vitro

30 July 2017

cites work

1 reference

12 December 2020

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

1 reference

12 December 2020

Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors

1 reference

12 December 2020

Cost of Treating Advanced Colorectal Cancer: A Retrospective Comparison of Treatment Regimens

1 reference

12 December 2020

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

12 December 2020

Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity

1 reference

12 December 2020

Comparative studies on the immunosuppressive effect among 5'-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil

1 reference

12 December 2020

Oral chemotherapy: rationale and future directions

1 reference

12 December 2020

Purification and properties of cytidine deaminase from normal and leukemic granulocytes

1 reference

12 December 2020

Thymidine phosphorylase is angiogenic and promotes tumor growth.

1 reference

12 December 2020

Deoxycytidylate Deaminase and Deoxycytidine Deaminase in Normal and Neoplastic Human Tissues

1 reference

12 December 2020

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

1 reference

12 December 2020

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

12 December 2020

Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges

1 reference

12 December 2020

Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer

1 reference

12 December 2020

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts

1 reference

12 December 2020

Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine

1 reference

12 December 2020

Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine)

1 reference

12 December 2020

Anticachectic activity of 5'-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma

1 reference

12 December 2020

Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor

1 reference

12 December 2020

Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites

1 reference

12 December 2020

Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.

1 reference

12 December 2020

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

12 December 2020

Selective inhibition of spontaneous pulmonary metastasis of Lewis lung carcinoma by 5'-deoxy-5-fluorouridine

1 reference

12 December 2020

Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine

1 reference

12 December 2020

Fluorouracil: biochemistry and pharmacology

1 reference

12 December 2020

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

1 reference

12 December 2020

The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors

1 reference

12 December 2020

[Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group]

1 reference

12 December 2020

Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice

1 reference

12 December 2020

Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models

1 reference

12 December 2020

Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine.

1 reference

12 December 2020

Oral fluoropyrimidines in the treatment of colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006497231579

1 reference

Dimensions Publication ID

30 July 2017

1053363207

0 references

1 reference